0      0


Breakfast Activity/Non-CE-Accredited Satellite Symposium <br>Clinical Considerations for the Treatment of mTNBC and HR+/HER2- mBC with an ADC <br> Gilead </br> <br><i>Seating available on first-come, first-served basis </br></i><br><i>Seating available on first-come, first-served basis </br></i>


‐ Nov 11, 2023 7:45am

Melissa Carver, MSN, APRN, AOCN

You must be logged in and own this session in order to post comments.